Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study

OBJECTIVE: Diazepam nasal spray (Valtoco), indicated for acute treatment of frequent seizure activity (seizure clusters) in patients with epilepsy ≥6 years of age, is designed to be a rapid, noninvasive, socially acceptable route of administration. This interim analysis evaluated the safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Segal, Eric B., Tarquinio, Daniel, Miller, Ian, Wheless, James W., Dlugos, Dennis, Biton, Victor, Cascino, Gregory D., Desai, Jay, Hogan, R. Edward, Liow, Kore, Sperling, Michael R., Vazquez, Blanca, Cook, David F., Rabinowicz, Adrian L., Carrazana, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252651/
https://www.ncbi.nlm.nih.gov/pubmed/33942315
http://dx.doi.org/10.1111/epi.16901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252651/
https://www.ncbi.nlm.nih.gov/pubmed/33942315
http://dx.doi.org/10.1111/epi.16901

Ejemplares similares